Parsabiv
Biological Nephrology
NDC 55513-740-10
General payments
$1,319,040
Research payments
$554,132
Through program year 2019, $1,319,040 in general payments and $554,132 in research payments were reported against Parsabiv (Nephrology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | General | $1,319,040 | 9,622 |
| 2019 | Research | $554,132 | 84 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.
The top 5 of 35 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2019 where a state was reported.
Records
9,622 general · 84 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.